Patrik Jonsson
Patrik Jonsson is the President of Lilly Cardiometabolic Health at Eli Lilly & Company, where he advocates for the recognition of obesity as a chronic disease and has been instrumental in the company's initiatives to enhance the affordability and accessibility of weight-loss medications like Zepbound.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Patrik Jonsson, president of Lilly Cardiometabolic Health, said the company is committed to working with all parties to solve this problem.
7